Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,045,474
-
Share change
-
-727,853
-
Total reported value
-
$537,618,213
-
Put/Call ratio
-
140%
-
Price per share
-
$18.51
-
Number of holders
-
103
-
Value change
-
-$12,626,294
-
Number of buys
-
48
-
Number of sells
-
59
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q1 2021
As of 31 Mar 2021,
Kiniksa Pharmaceuticals Intern - COM (KNSA) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,045,474 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, PICTET ASSET MANAGEMENT LTD, BlackRock Inc., STATE STREET CORP, AMERIPRISE FINANCIAL INC, Avidity Partners Management LP, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.